# Protagonist Therapeutics, Inc: Form 8-K, filed Feb 25, 2026

- Company: [Protagonist Therapeutics, Inc](/companies/ptgx.md) (CIK 1377121)
- Form: 8-K
- Filed: 2026-02-25
- Accepted by EDGAR: Feb 25, 2026, 16:08 ET
- Period: 2026-02-25
- Accession: 0001104659-26-019658
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1377121/000110465926019658/tm267184d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1377121/000110465926019658/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1377121/000110465926019658/tm267184d1_8k.htm

Filed Feb 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-019658. Last ingested by Listed: Nov 6, 2026, 12:26 ET. No prices; not investment advice.